{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:12:38Z","timestamp":1785427958766,"version":"3.56.0"},"reference-count":48,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Tissue Engineering Part C: Methods"],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:p>\n                    Tumor models based on cancer cell lines cultured two-dimensionally (2D) on plastic lack histological complexity and functionality compared to the native microenvironment. Xenogenic mouse tumor models display higher complexity but often do not predict human drug responses accurately due to species-specific differences. We present here a three-dimensional (3D)\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    colon cancer model based on a biological scaffold derived from decellularized porcine jejunum (small intestine submucosa+mucosa, SISmuc). Two different cell lines were used in monoculture or in coculture with primary fibroblasts. After 14 days of culture, we demonstrated a close contact of human Caco2 colon cancer cells with the preserved basement membrane on an ultrastructural level as well as morphological characteristics of a well-differentiated epithelium. To generate a tissue-engineered tumor model, we chose human SW480 colon cancer cells, a reportedly malignant cell line. Malignant characteristics were confirmed in 2D cell culture: SW480 cells showed higher vimentin and lower E-cadherin expression than Caco2 cells. In contrast to Caco2, SW480 cells displayed cancerous characteristics such as delocalized E-cadherin and nuclear location of \u03b2-catenin in a subset of cells. One central drawback of 2D cultures\u2014especially in consideration of drug testing\u2014is their artificially high proliferation. In our 3D tissue-engineered tumor model, both cell lines showed decreased numbers of proliferating cells, thus correlating more precisely with observations of primary colon cancer in all stages (UICC I-IV). Moreover, vimentin decreased in SW480 colon cancer cells, indicating a mesenchymal to epithelial transition process, attributed to metastasis formation. Only SW480 cells cocultured with fibroblasts induced the formation of tumor-like aggregates surrounded by fibroblasts, whereas in Caco2 cocultures, a separate Caco2 cell layer was formed separated from the fibroblast compartment beneath. To foster tissue generation, a bioreactor was constructed for dynamic culture approaches. This induced a close tissue-like association of cultured tumor cells with fibroblasts reflecting tumor biopsies. Therapy with 5-fluorouracil (5-FU) was effective only in 3D coculture. In conclusion, our 3D tumor model reflects human tissue-related tumor characteristics, including lower tumor cell proliferation. It is now available for drug testing in metastatic context\u2014especially for substances targeting tumor\u2013stroma interactions.\n                  <\/jats:p>","DOI":"10.1089\/ten.tec.2015.0557","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T03:58:04Z","timestamp":1462247884000},"page":"621-635","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":55,"title":["Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold"],"prefix":"10.1177","volume":"22","author":[{"given":"Sarah","family":"Nietzer","sequence":"first","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentin","family":"Baur","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sieber","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hansmann","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schwarz","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Stoffer","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heide","family":"H\u00e4fner","sequence":"additional","affiliation":[{"name":"\u201d Fraunhofer Institute Interfacial Engineering and Biotechnology IGB","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gasser","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Waaga-Gasser","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Walles","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]},{"name":"\u201d Fraunhofer Institute Interfacial Engineering and Biotechnology IGB","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Dandekar","sequence":"additional","affiliation":[{"name":"University Hospital of the Julius-Maximilians University","place":["Germany"]},{"name":"\u201d Fraunhofer Institute Interfacial Engineering and Biotechnology IGB","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.338.6103.29"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/35094059"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1695"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1085"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1877"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/03008207.2015.1060970"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2548"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1658"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0568"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tec.2013.0446"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2013.11.009"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.2006.0388"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2010.03.015"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2015.01.005"},{"key":"e_1_3_3_17_2","first-page":"50460","article-title":"Tissue engineering of a human 3D in vitro tumor test system","volume":"78","author":"Moll C.","year":"2013","unstructured":"Moll C., , Reboredo J., , Schwarz T., , Appelt A., , Schurlein S., , Walles H., , and Nietzer S. Tissue engineering of a human 3D in vitro tumor test system. J Vis Exp, 78, 50460, 2013.","journal-title":"J Vis Exp"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i22.2743"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.2000.1029"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.05.001"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00206-8"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ac15e1"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2014.0200"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1039\/C3FO60675A"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201400004"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.06.035"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2009.01.003"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/35077241"},{"key":"e_1_3_3_29_2","first-page":"153","article-title":"Colorectal carcinoma: pathologic aspects","volume":"3","author":"Fleming M.","year":"2012","unstructured":"Fleming M., , Ravula S., , Tatishchev S.F., , and Wang H.L. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol, 3, 153, 2012.","journal-title":"J Gastrointest Oncol"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-010-0038-3"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200601018"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063854"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64856-0"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-008-9167-1"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.171610498"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.034"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03688"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0784"},{"key":"e_1_3_3_39_2","volume-title":"Frankfurt am Main","author":"Herdrich K.","year":"2003","unstructured":"Herdrich K., , and Weinberger H. Selected Schedules of Therapy for Malignant Tumors. Frankfurt am Main, Germany: Baxter Oncology, 2003."},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605780"},{"key":"e_1_3_3_41_2","first-page":"1029","article-title":"Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy","volume":"61","author":"Yoshikawa R.","year":"2001","unstructured":"Yoshikawa R., , Kusunoki M., , Yanagi H., , Noda M., , Furuyama J.I., , Yamamura T., , and Hashimoto-Tamaoki T. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res, 61, 1029, 2001.","journal-title":"Cancer Res"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2211"},{"key":"e_1_3_3_43_2","first-page":"3032","article-title":"Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients","volume":"6","author":"Bocci G.","year":"2000","unstructured":"Bocci G., , Danesi R., , Di Paolo A.D., , Innocenti F., , Allegrini G., , Falcone A., , Melosi A., , Battistoni M., , Barsanti G., , Conte P.F., , and Del Tacca M. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients. Clin Cancer Res, 6, 3032, 2000.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11712"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.4.642"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02034-1"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.1.136"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198809013190901"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0191"}],"container-title":["Tissue Engineering Part C: Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/ten.tec.2015.0557","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ten.tec.2015.0557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ten.tec.2015.0557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:08:58Z","timestamp":1779253738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/ten.tec.2015.0557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7,1]]}},"alternative-id":["10.1089\/ten.tec.2015.0557"],"URL":"https:\/\/doi.org\/10.1089\/ten.tec.2015.0557","relation":{},"ISSN":["1937-3384","1937-3392"],"issn-type":[{"value":"1937-3384","type":"print"},{"value":"1937-3392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}